| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
112,000,000 |
| Market
Cap: |
16.09(B) |
| Last
Volume: |
1,178,515 |
Avg
Vol: |
872,493 |
| 52
Week Range: |
$73.2 - $142.24 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Specialized Health Services |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 704 |
| Guru Rank Value : 2 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile DaVita is a healthcare provider focused on transforming care delivery to improve quality of life for patients globally. Co.'s U.S. dialysis business is a provider of kidney dialysis services for patients suffering from end stage renal disease. Co.'s U.S. dialysis services include: outpatient hemodialysis services, hospital inpatient hemodialysis services, and home-based dialysis services. Co.'s ancillary services relate primarily to its main business of providing kidney care services. Co.'s U.S. ancillary services include: integrated kidney care services and physician services. Co. also operates or provides administrative services to various outpatient dialysis centers.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
25,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$1,909,675 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
5,030 |
146,967 |
156,761 |
204,494 |
| Total Sell Value |
$698,214 |
$18,187,543 |
$19,184,642 |
$23,884,304 |
| Total People Sold |
1 |
5 |
5 |
7 |
| Total Sell Transactions |
1 |
6 |
7 |
15 |
| End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hilger James K |
Interim CFO and CAO |
• – – |
2016-05-23 |
4 |
D |
$77.37 |
$664,144 |
D/D |
(8,584) |
20,563 |
|
- |
|
| Hilger James K |
Interim CFO and CAO |
• – – |
2016-05-23 |
4 |
OE |
$55.34 |
$664,080 |
D/D |
12,000 |
29,147 |
|
- |
|
| Thiry Kent J |
Chairman and CEO |
• • – |
2016-05-20 |
4 |
S |
$76.99 |
$2,531,579 |
D/D |
(32,880) |
39,184 |
|
- |
|
| Zumwalt Leanne M |
Grp VP, Purch & Public Affairs |
• – – |
2016-05-17 |
4 |
S |
$77.08 |
$41,469 |
D/D |
(538) |
8,585 |
|
- |
|
| Kogod Dennis |
Pres, HCP & CEO, DVA Int. |
• – – |
2016-05-17 |
4 |
S |
$77.35 |
$1,369,116 |
D/D |
(17,700) |
18,766 |
|
- |
|
| Hilger James K |
Interim CFO and CAO |
• – – |
2016-05-16 |
4 |
S |
$75.59 |
$301,073 |
D/D |
(3,983) |
17,147 |
|
- |
|
| Staffieri Michael David |
COO, Kidney Care |
• – – |
2016-05-16 |
4 |
S |
$75.69 |
$373,447 |
D/D |
(4,934) |
12,279 |
|
- |
|
| Rodriguez Javier |
CEO-Kidney Care |
• – – |
2016-05-16 |
4 |
AS |
$75.44 |
$2,751,093 |
D/D |
(36,466) |
64,264 |
|
- |
|
| Jiganti Jeanine Marie |
Chief Compliance Officer |
• – – |
2016-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,323 |
4,778 |
|
- |
|
| Hilger James K |
Interim CFO and CAO |
• – – |
2016-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,654 |
21,130 |
|
- |
|
| Valine Roger |
Director |
– • – |
2016-05-12 |
4 |
S |
$76.34 |
$627,534 |
D/D |
(8,220) |
324 |
|
- |
|
| Valine Roger |
Director |
– • – |
2016-05-12 |
4 |
D |
$76.32 |
$746,410 |
D/D |
(9,780) |
8,544 |
|
- |
|
| Valine Roger |
Director |
– • – |
2016-05-12 |
4 |
OE |
$41.47 |
$746,370 |
D/D |
18,000 |
18,324 |
|
- |
|
| Kogod Dennis |
Pres, HCP & CEO, DVA Int. |
• – – |
2016-05-10 |
4 |
S |
$76.25 |
$3,053,660 |
D/D |
(40,048) |
36,466 |
|
- |
|
| Kogod Dennis |
Pres, HCP & CEO, DVA Int. |
• – – |
2016-05-10 |
4 |
D |
$76.04 |
$9,596,400 |
D/D |
(126,202) |
61,202 |
|
- |
|
| Kogod Dennis |
Pres, HCP & CEO, DVA Int. |
• – – |
2016-05-10 |
4 |
OE |
$55.34 |
$9,596,275 |
D/D |
166,250 |
146,466 |
|
- |
|
| Waters Kathleen Alyce |
Chief Legal Officer |
• – – |
2016-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
7,041 |
7,041 |
|
- |
|
| Nehra John M |
Director |
– • – |
2016-05-06 |
4 |
S |
$75.56 |
$1,232,761 |
D/D |
(16,314) |
665 |
|
- |
|
| Nehra John M |
Director |
– • – |
2016-05-06 |
4 |
D |
$75.83 |
$1,492,789 |
D/D |
(19,686) |
16,979 |
|
- |
|
| Nehra John M |
Director |
– • – |
2016-05-06 |
4 |
OE |
$41.47 |
$1,492,740 |
D/D |
36,000 |
36,665 |
|
- |
|
| Desoer Barbara J |
Director |
– • – |
2016-04-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
642 |
0 |
|
- |
|
| Rodriguez Javier |
CEO-Kidney Care |
• – – |
2016-04-11 |
4 |
AS |
$73.51 |
$6,609,098 |
D/D |
(89,912) |
100,730 |
|
- |
|
| Rodriguez Javier |
CEO-Kidney Care |
• – – |
2016-04-11 |
4 |
D |
$74.10 |
$9,392,546 |
D/D |
(126,755) |
190,642 |
|
- |
|
| Rodriguez Javier |
CEO-Kidney Care |
• – – |
2016-04-11 |
4 |
OE |
$43.35 |
$9,392,514 |
D/D |
216,667 |
317,397 |
|
- |
|
| Valine Roger |
Director |
– • – |
2016-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
324 |
324 |
|
- |
|
2937 Records found
|
|
Page 29 of 118 |
|
|
5.13 (3.7%) 
